Investors Purchase High Volume of Put Options on ARK Genomic Revolution ETF (BATS:ARKG)

ARK Genomic Revolution ETF (BATS:ARKG) was the target of unusually large options trading activity on Wednesday. Stock traders purchased 79,250 put options on the stock. This is an increase of 700% compared to the typical daily volume of 9,906 put options.

ARK Genomic Revolution ETF Trading Down 0.1 %

Shares of BATS:ARKG opened at $25.57 on Thursday. The company’s 50 day moving average is $24.78 and its 200-day moving average is $24.99.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the stock. National Bank of Canada FI boosted its position in shares of ARK Genomic Revolution ETF by 28.4% during the third quarter. National Bank of Canada FI now owns 4,155 shares of the company’s stock worth $106,000 after buying an additional 920 shares during the period. IHT Wealth Management LLC acquired a new stake in ARK Genomic Revolution ETF during the 3rd quarter worth about $203,000. Sanctuary Advisors LLC acquired a new position in ARK Genomic Revolution ETF in the 2nd quarter valued at approximately $222,000. Hilltop Holdings Inc. acquired a new position in shares of ARK Genomic Revolution ETF in the third quarter worth $237,000. Finally, Choreo LLC bought a new stake in ARK Genomic Revolution ETF in the second quarter worth approximately $314,000.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.